Lataa...
Effect of a Chikungunya Virus–Like Particle Vaccine on Safety and Tolerability Outcomes: A Randomized Clinical Trial
IMPORTANCE: Chikungunya virus (CHIKV) is a mosquito-borne Alphavirus prevalent worldwide. There are currently no licensed vaccines or therapies. OBJECTIVE: To evaluate the safety and tolerability of an investigational CHIKV virus–like particle (VLP) vaccine in endemic regions. DESIGN, SETTING, AND P...
Tallennettuna:
| Julkaisussa: | JAMA |
|---|---|
| Päätekijät: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Medical Association
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7156994/ https://ncbi.nlm.nih.gov/pubmed/32286643 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2020.2477 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|